|

GBP/USD extends slide to 1.2815 amid Brexit concerns

  • The pound is the worst performer among majors, weakened by no-deal Brexit concerns.
  • GBP/USD falling for the first time after a 5-day rally.

The GBP/USD pair broke to the downside after the beginning of the US session and printed a fresh daily low at 1.2815. From yesterday’s high, it has fallen more than a hundred pips as it continues to erase weekly gains. As of writing, it was trading at 1.2830, posting the first daily loss in a week.

The pound is among the weakest currencies on Thursday. The slide accelerated as investors digest the document presented by the UK Brexit Department with contingency plans in the case of a no-deal Brexit. The technical note is the first of a serious, presenting possible scenarios if a deal is not reached before March 2019.

Weaker-than-expected US PMI data failed to push the pair to the upside that resumed the downside during the US session. The flash PMI Composite Index fell to 55.0 in August, the lowest in 4 months. “The US economy lost a little pace in August, according to the flash PMI, but continued to grow at a solid rate. The PMI is indicative of the economy growing at an annualised rate of roughly 2.5%, down from a 3.0% indicated rate in July”, said Chris Williamson, Chief Business Economist at IHS Markit.

GBP/USD Short-term Levels to watch

To the downside, immediate support is seen around the 1.2790 followed by 1.2775 (uptrend line from Aug 15 low) and 1.2750. On the upside, resistance could be seen at 1.2845 (European session low), 1.2910 (Aug 23 high) and 1.2935 (Aug 22 high).

Author

Matías Salord

Matías started in financial markets in 2008, after graduating in Economics. He was trained in chart analysis and then became an educator. He also studied Journalism. He started writing analyses for specialized websites before joining FXStreet.

More from Matías Salord
Share:

Editor's Picks

GBP/USD strengthens to near 1.3400 as UK political risk fades

The GBP/USD pair gathers strength near 1.3395 during the Asian trading hours on Thursday, bolstered by fading domestic political uncertainty. However, hawkish minutes from the Federal Reserve and renewed tensions between the US and Iran might support the US Dollar and cap the upside for the major pair.


EUR/USD sticks to positive bias above 1.1400; Mideast tensions cap gains

The EUR/USD pair attracts some buyers for the second straight day, though it lacks follow-through and remains confined within the previous day's range during the Asian session on Thursday. Spot prices currently trade around the 1.1420 area, up less than 0.10% for the day, and remain at the mercy of the US Dollar price dynamics.

Gold sees more pain as Iran tensions revive inflation fears

Gold price reflects signs of softness on Thursday, trading 0.5% lower at around $4,056 during the Asian trading session. The precious metal is under pressure as Middle East hostilities have revived fears of high global inflation, a scenario that discourages major central banks from easing monetary conditions. This framework bodes well for interest-bearing assets, but diminishes the appeal of non-yielding assets, such as Gold.


Ripple and Stellar extend downside as weakening technicals

Ripple and Stellar extend losses on Thursday, correcting over 6% and 10%, respectively, so far this week. XRP falls below $1.090, while XLM posts a fifth consecutive day of correction and closes below key support levels.

2.50%: Why the Kiwi's first hike in three years is a wager on a number nobody can see
The Reserve Bank of New Zealand (RBNZ) raised the Official Cash Rate (OCR) by 25 basis points to 2.50% at 02:00 GMT on Wednesday, its first hike in three years and the moment the bank that cut deeper than any G10 peer last cycle turned to face the other way.
Bye, forward guidance: How to trade when central banks choose silence

Central banks have spent years telling markets what might come next. Now, traders face the possibility that they say a lot less. From the Federal Reserve to the European Central Bank and the Bank of England, policymakers are pushing back against forward guidance.